- ►ksu.edu.sa [PDF] JP Bantle, RJ Wylie, AL Albright, CM Apovian, NG … - 2006 - repository.ksu.edu.sa M edical nutrition therapy (MNT) is important in preventing diabetes, managing existing
diabetes, and preventing, or at least slowing, the rate of development of diabetes
complications. It is, therefore, important at all levels of di- abetes prevention (see Table 1). ... Cited by 66 - Related articles - View as HTML - All 3 versions
- ►diabetesjournals.org J Martin, ZQ Wang, XH Zhang, D Wachtel, J … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were
evaluated. After baseline, subjects were placed on a sulfonylurea (glipizide gastrointestinal therapeutic
system 5 mg/day) with placebo for 3 months. Subjects were then randomized in a double- ... Cited by 50 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org C De Block… - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—During 48-h CGM, glycemia reached target (80–110 mg/dl) in only 22 ± 18%, was
>140 mg/dl in 39 ± 27%, and was <60 mg/dl in 5 ± 10% of the time. Patients on subcutaneous
versus intravenous insulin had more glycemia readings >110 mg/dl (P = 0.016). Glycemia ... Cited by 40 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org N Kleefstra, ST Houweling, FGA Jansman, KH … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this 6-month double-blind study, patients with an
HbA 1c (A1C) >8% and insulin requirements of >50 units/day were randomly assigned to receive
treatment with placebo or 500 or 1,000 μg chromium daily in the form of chromium ... Cited by 35 - Related articles - BL Direct - All 9 versions
CL Broadhurst, P Domenico - Diabetes Technology & Therapeutics, 2006 - liebertonline.com Chromium (Cr) picolinate (CrPic) is a widely used nutritional supplement for optimal insulin
function. A relationship among Cr status, diabetes, and associated pathologies has been
estab- lished. Virtually all trials using CrPic supplementation for subjects with diabetes ... Cited by 29 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org EM Balk, A Tatsioni, AH Lichtenstein, J Lau, AG … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Forty-one studies met criteria, almost half of which were of poor quality. Among participants
with type 2 diabetes, chromium supplementation improved glycosylated hemoglobin levels by
−0.6% (95% CI −0.9 to −0.2) and fasting glucose by −1.0 mmol/l (−1.4 to −0.5) but not ... Cited by 23 - Related articles - BL Direct - All 13 versions
PR Trumbo, KC Ellwood - Nutrition reviews, 2006 - ingentaconnect.com The labeling of both health claims that meet signifi- cant scientific agreement (SSA) and qualified
health claims on conventional foods and dietary supplements requires pre-market approval by
the US Food and Drug Administration (FDA). Approval by the FDA involves, in part, a ... Cited by 13 - Related articles - BL Direct - All 7 versions
DMR Rev - Diabetes Metab Res Rev, 2008 - files.meetup.com 1Alpha Therapy Center, 4626 Weber Road, Suite 100, Corpus Christi, TX 78411; 361.852.0600
(voice), USA 2Global Medical Care, 5833 Spohn Drive, Suite # 301, Corpus Christi, TX
78414; 361.880.4154 (voice), USA 3JERIKA Research Foundation, Redwood City, CA ... Cited by 13 - Related articles - View as HTML - BL Direct - All 5 versions
- ►diabetesjournals.org N Kleefstra, ST Houweling, SJL Bakker, S … - Diabetes Care, 2007 - Am Diabetes Assoc OBJECTIVE—Chromium treatment has been reported to improve glycemic control in patients
with type 2 diabetes. However, concern exists about the possible toxic effects of chromium
picolinate. The aim of this study was to determine the effect of chromium treatment in the ... Cited by 12 - Related articles - BL Direct - All 8 versions
N Sreejayan, F Dong, MR Kandadi, X Yang, … - Obesity, 2008 - obesity-cme.abbmcertification.org IntroductIon Insulin resistance, concomitant with diabetes, metabolic syn- drome, obesity, and
hypertension, is a major risk factor for the development and progression of cardiovascular
diseases, the leading causes of mortality and morbidity (1). The currently accepted ... Cited by 9 - Related articles - View as HTML - All 5 versions
